The exponential rise in opioid prescriptions by pharmaceutical companies, despite awareness of their addictive nature, has led to a staggering toll of over 760,000 lives lost to drug overdoses since ...

Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

Please provide your email address to receive an email when new articles are posted on . Buprenorphine buccal film treatment led to greater reductions in pain than placebo among patients with moderate ...

Generic versions of Suboxone (buprenorphine and naloxone; Indivior) Sublingual Film have been made available by Sandoz and Alvogen. Generic versions of Suboxone (buprenorphine and naloxone; Indivior) ...

WARREN, N.J., Aug. 31 /PRNewswire/ -- MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, ...

SLOUGH, England and RICHMOND, Va., July 24, 2020 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") announced that it has reached an agreement with the United States Department of ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received final approval from the U.S. Food and ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. WARNING: Important safety information is provided in a boxed warning ...

Federal prosecutors on Tuesday charged the British pharmaceutical company Indivior with fraud, making a case that the company had swindled Medicare, Medicaid, and other health care providers by ...